Elsevier

Schizophrenia Research

Volume 192, February 2018, Pages 442-456
Schizophrenia Research

D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia

https://doi.org/10.1016/j.schres.2017.05.017Get rights and content

Abstract

Converging evidence indicates that the prefrontal cortex is critically involved in executive control and that executive dysfunction is implicated in schizophrenia. Reduced dopamine D2/D3 receptor binding potential has been reported in schizophrenia, and the correlations with neuropsychological test scores have been positive and negative for different tasks. The aim of this study was to examine the relation between dopamine D2/D3 receptor levels with frontal and temporal neurocognitive performance in schizophrenia. Resting-state 18F-fallypride positron emission tomography was performed on 20 medication-naïve and 5 previously medicated for brief earlier periods patients with schizophrenia and 19 age- and sex-matched healthy volunteers. Striatal and extra-striatal dopamine D2/D3 receptor levels were quantified as binding potential using fallypride imaging. Magnetic resonance images in standard Talairach position and segmented into gray and white matter were co-registered to the fallypride images, and the AFNI stereotaxic atlas was applied. Two neuropsychological tasks known to activate frontal and temporal lobe function were chosen, specifically the Wisconsin Card Sorting Test (WCST) and the California Verbal Learning Test (CVLT). Images of the correlation coefficient between fallypride binding and WCST and CVLT performance showed a negative correlation in contrast to positive correlations in healthy volunteers. The results of this study demonstrate that lower fallypride binding potential in patients with schizophrenia may be associated with better performance. Our findings are consistent with previous studies that failed to find cognitive improvements with typical dopamine-blocking medications.

Introduction

Neurocognitive impairments are a core feature of schizophrenia, with the largest effect sizes (> 1.5 z-score differences) reported in both executive function and verbal memory (Bilder et al., 2000, Dickinson and Harvey, 2009, Reichenberg et al., 2010, Vyas et al., 2012). Impairments in executive function are found to predict poor functional outcome, failure in treatment interventions and limited rehabilitation (Green et al., 2000). Executive function includes multiple cognitive constructs regulated by the coordination of multi-operational neural systems and is a linchpin of cognitive ability (Bressler and Menon, 2010). It has been linked in functional neuroimaging studies to the fronto-striatal-thalamic network thought to be associated with the pervasive cognitive deficits reported in schizophrenia (Andreasen, 1997, Andreasen et al., 1997, Buchsbaum et al., 1999, Hazlett et al., 2008, Kessler et al., 1993). This network, with its detailed neuroanatomical structure (Alexander et al., 1986), is critical for performing tasks such as the Wisconsin Card Sorting Test (WCST) that are known to elicit performance impairments in schizophrenia, and its dysfunctional operation demonstrated in unmedicated schizophrenia patients confirmed with functional brain imaging approaches (see review and meta-analysis, Buchsbaum et al., 2005). Abnormalities in the fronto-striatal-thalamic network have also been demonstrated in functional magnetic resonance imaging (fMRI) studies of psychosis-prone individuals (Ettinger et al., 2013, Kumari et al., 2008).

While the striatum and thalamus are known to have the highest dopamine receptor concentrations in the brain, the frontal and temporal lobes also contains significant numbers of receptors on rigorous postmortem examination (Joyce et al., 1991). High-affinity dopamine receptor ligands developed for positron emission tomography (PET) make it possible to assess the fronto-striato-thalamic distribution of dopamine binding. In healthy subjects significant extra-striatal binding has been demonstrated (Buchsbaum et al., 2006, Farde et al., 1997, Lehrer et al., 2005, Mukherjee et al., 2002). In unmedicated and never-medicated subjects with schizophrenia, abnormalities in extra-striatal dopaminergic neurotransmission have been reported in the prefrontal cortex (Lehrer et al., 2010a) and the medial dorsal nucleus of the thalamus (Buchsbaum et al., 2006, Kessler et al., 2009, Lehrer et al., 2005, Suhara et al., 2002, Talvik et al., 2003, Yasuno et al., 2004). The earliest report by Suhara and colleagues (Suhara et al., 2002) showed lower binding potential in the thalamus in patients with schizophrenia compared with controls (in retrospect, a one-tailed test would have been p = 0.03; see their Table 1). A single photon emission computed tomography (SPECT) study using epidepride (Glenthoj et al., 2006) failed to detect binding reduction in the thalamus in patients with schizophrenia, however this negative finding may be due to lower resolution in SPECT imaging. In our studies with higher-resolution PET the decreased binding in schizophrenia was most marked in the medial dorsal nucleus isolated by tracing on co-registered MRI (Lehrer et al., 2010b), whereas in healthy subjects, the medial dorsal nucleus showed relatively higher binding compared with other thalamic nuclei (Takahashi et al., 2006).

There is increasing evidence that patients with schizophrenia exhibit impairment on executive function tasks, such as the WCST and the California Verbal Learning Test (CVLT), which is precisely aligned to non-motor fronto-striatal-thalamic circuits. Performance deficits in WCST categories achieved and perseverative errors has been widely documented in first-episode psychosis (Addington et al., 2003, Bilder et al., 2000, Brickman et al., 2004, Fagerlund et al., 2006, Mohamed et al., 1999, Riley et al., 2000, Townsend et al., 2001), and meta-analyses (Fatouros-Bergman et al., 2014, Fioravanti et al., 2005, Li, 2004). Functional MRI and PET frontal activation deficits have been found in schizophrenia (Berman et al., 1995, Patel et al., 2010, Riehemann et al., 2001) and an activation likelihood estimation meta-analysis on a series of fMRI studies using the WCST identified the frontal lobe, thalamus and striatum as important activation sites (Buchsbaum et al., 2005). The prevailing evidence from imaging studies suggests more widespread brain activations during WCST performance (Barcelo et al., 1997, Nyhus and Barcelo, 2009). An EEG study of healthy individuals revealed increased activity during task performance across all frequency bands in the frontal and temporo-parieto-occipital regions (except alpha), indicating that executive functioning skills underlying performance on the WCST may represent the operation of a more complex and widespread communication network (Gonzalez-Hernandez et al., 2002). Since dopamine projections are widespread, dopamine deficits may have profound effects on higher-order cognition (Vyas et al., 2011).

The CVLT, a measure of verbal learning and memory that relies on serial-order and semantic-cluster strategies, also involves frontal areas, as demonstrated in patients with focal lesions (Alexander et al., 2003, Baldo et al., 2002), striatal activity in PET studies of normal aging (Brickman et al., 2003), and reduced functional connectivity between the medial prefrontal, thalamus and striatum in fMRI studies of mild cognitive impairment (Liang et al., 2011). Deficits in the CVLT have consistently been reported in early-onset (Brickman et al., 2004, McClellan et al., 2004, Oie and Rund, 1999, Roofeh et al., 2006), first-episode (Bilder et al., 2000, Hill et al., 2001, Saykin et al., 1994), chronic/multiple-episode (Aleman et al., 1999, Heinrichs and Zakzanis, 1998) patients with schizophrenia, high risk studies (Hill et al., 2004, Paulsen et al., 1995), and a meta-analysis (Szoke et al., 2008).

Four resting [F-18]fallypride PET studies in schizophrenia have reported low dopamine receptor binding potential in the medial dorsal nucleus of the thalamus (Buchsbaum et al., 2006, Kessler et al., 2009, Lehrer et al., 2010a, Yasuno et al., 2004), and in the prefrontal cortex in patients with schizophrenia (Lehrer et al., 2010a). A study using the high-affinity radioligand [11C]FLB 457 PET also showed low D2/D3 receptor binding in the right medial thalamus in drug-naïve patients with schizophrenia compared with controls (Talvik et al., 2003).

Since excess dopaminergic activity has been hypothesized to be involved in the pathophysiology of schizophrenia, we might expect that poor WCST performance would be associated with a more active dopamine system. In subjects with schizophrenia, higher 18F-FDOPA uptake has been associated with poor task performance on the WCST perseverative errors (Meyer-Lindenberg et al., 2002). Another study showed that more perseverative errors on the CANTAB Set shifting task were significantly associated with lower binding potential in patients with schizophrenia (Fagerlund et al., 2013). Ghahremani and colleagues reported better (shorter) stop-signal reaction time associated with higher fallypride binding potential in the striatum (Ghahremani et al., 2012).

Animal models have demonstrated that the striatum plays an important role in decision-making and performing goal-directed actions (Ito and Doya, 2009). Human choice behavior has been conceptualized as based on two decision systems, namely model-free and model-based, where the former system is influenced by making predictions based on previous experiences while the latter goal-directed system plans a set of actions based on future prospects. A recent study used a two-step decision choice task during fMRI combined with 18F-FDOPA PET in healthy participants, reported that higher levels of presynaptic dopamine in the ventral striatum was associated with greater model-based coding in the lateral prefrontal cortices (Deserno et al., 2014). Importantly, Ito et al. observed a significant negative correlation between the binding potential of dopamine D2 receptors and endogenous dopamine synthesis rate (Ito et al., 2011) indicating that high dopa uptake and low binding potential are alternate assessments.

The goal of the current study was to investigate the relationship between dopamine D2/D3 receptor density, as indexed by [18F]fallypride, and executive function (as measured by the WCST), and episodic memory (as measured with CVLT), in a group of medication-naïve patients with schizophrenia and matched healthy volunteers. Because previous studies have shown low dopamine D2/D3 receptor binding potential in schizophrenia, we hypothesized that 1) there will be a positive association between high binding potential and performance in healthy volunteers, 2) this association will be less pronounced in patients with schizophrenia due to dysfunctional dopamine deployment in the frontal cortex, 3) heterogeneous dopamine deficits in patients with schizophrenia will diminish regional brain fallypride binding potential vs. neuropsychological performance correlations, and 4) there will be an association between binding potential and short-delay recall (model-free) in the ventral striatum in healthy volunteers, while a lower correlation will be found between binding potential and WCST categories achieved (model-based).

Section snippets

Participants

Twenty-five patients with schizophrenia (18 men; 7 women; age mean ± SD: 31.6 ± 12.2) were recruited from the greater Dayton, Ohio area, and assessed and consented as previously described (Buchsbaum et al., 2006, Lehrer et al., 2010a). We clinically evaluated participants (Buchsbaum et al., 2006) (n = 15) using the Comprehensive Assessment of Symptoms and History (Andreasen et al., 1992) and the Brief Psychiatric Rating Scale (Overall, 1972, Overall, 1976). We clinically assessed later subjects (n = 

[F-18]Fallypride and WCST

In the fronto-striatal-thalamic region set, there was no significant difference between healthy volunteers and patients on the four WCST scores and no difference was confirmed with the Hotelling T2 test (F = 3.08, df = 4, 39, p = 0.23). The Hotelling T2 was at a trend level for the 13 BP values (F = 1.17, df = 13, 30, p = 0.054).

The correlation coefficients between fallypride binding potential and WCST are shown in Fig. 1. Healthy volunteers tended to show positive correlations indicating better

Discussion

To our knowledge, this study represents the first comprehensive investigation of the association between both striatal and extrastriatal D2/D3 receptor binding potential with executive function and verbal learning in medication-naïve (5 drug-free) patients with schizophrenia. The most important findings of this study are five-fold. Firstly, we found a positive correlation between binding potential and task performance on the WCST and CVLT in healthy volunteers. Secondly, we found lower or

Conflict of interest

All authors declare that they have no conflicts of interest.

Contributors

Prof Buchsbaum and Dr Lehrer designed the study. Dr Lehrer recruited, diagnosed and supervised the data collection. Dr Doninger, Dr Christian, and Dr Merrill quantified, co-registered and obtained ROI files. Dr Vyas, Dr Lehrer and Prof Buchsbaum managed the literature searches and analyses. Prof Mukherjee developed [F-18]Fallypride and supervised the synthesis. Prof Buchsbaum and Dr Vyas undertook the statistical analysis. Dr Vyas wrote the first draft of the manuscript. All authors contributed

Acknowledgements

We are grateful to all patients and healthy volunteers who participated in our study. Dr. Vyas is supported by a Winston Churchill Travelling Fellowship by the Winston Churchill Memorial Trust. Major funding was provided by the Kettering Health Network Foundation. Additional support was provided by a grant to Dr. Buchsbaum, Anatomy and function of the thalamus in schizophrenia MH60023 and by the Department of Psychiatry, University of California, San Diego. The support of the United States Air

References (118)

  • B. Fagerlund et al.

    Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders

    Schizophr. Res.

    (2006)
  • H. Fatouros-Bergman et al.

    Meta-analysis of cognitive performance in drug-naive patients with schizophrenia

    Schizophr. Res.

    (2014)
  • D.C. Glahn et al.

    Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis

    Biol. Psychiatry

    (2008)
  • M.F. Green et al.

    The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

    Biol. Psychiatry

    (2002)
  • R.M. Kessler et al.

    Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride

    Brain Res.

    (1993)
  • R.M. Kessler et al.

    Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects

    Biol. Psychiatry

    (2009)
  • V. Kumari et al.

    Prepulse inhibition and “psychosis-proneness” in healthy individuals: an fMRI study

    Eur. Psychiatry

    (2008)
  • M.G. Lanser et al.

    Perseveration in schizophrenia: failure to generate a plan and relationship with the psychomotor poverty subsyndrome

    Psychiatry Res.

    (2002)
  • D. Lehrer et al.

    18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls

    Schizophr. Res.

    (2010)
  • C.S.R. Li

    Do schizophrenia patients make more perseverative than non-perseverative errors on the Wisconsin card sorting test? A meta-analytic study

    Psychiatry Res.

    (2004)
  • J. McClellan et al.

    Neuropsychological functioning in early onset psychotic disorders

    Schizophr. Res.

    (2004)
  • J. Mukherjee et al.

    Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer

    Nucl. Med. Biol.

    (1995)
  • E. Nyhus et al.

    The Wisconsin card sorting test and the cognitive assessment of prefrontal executive functions: a critical update

    Brain Cogn.

    (2009)
  • J.D. Power et al.

    Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion

    NeuroImage

    (2012)
  • S. Remillard et al.

    The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year followup study

    Schizophr. Res.

    (2005)
  • E.M. Riley et al.

    Neuropsychological functioning in first-episode psychosis--evidence of specific deficits

    Schizophr. Res.

    (2000)
  • D. Roofeh et al.

    Deficits in memory strategy use are related to verbal memory impairments in adolescents with schizophrenia-spectrum disorders

    Schizophr. Res.

    (2006)
  • A. Aleman et al.

    Memory impairment in schizophrenia: a meta-analysis

    Am. J. Psychiatr.

    (1999)
  • G.E. Alexander et al.

    Parallel organization of functionally segregated circuits linking basal ganglia and cortex

    Annu. Rev. Neurosci.

    (1986)
  • M.P. Alexander et al.

    California verbal learning test: performance by patients with focal frontal and non-frontal lesions

    Brain

    (2003)
  • N. Andreasen

    The role of the thalamus in schizophrenia

    Can. J. Psychiatr.

    (1997)
  • N. Andreasen et al.

    The comprehensive assessment of symptoms and history (CASH): an instrument for assessing diagnosis and psychopathology

    Arch. Gen. Psychiatry

    (1992)
  • J.V. Baldo et al.

    Memory performance on the California verbal learning test-II: findings from patients with focal frontal lesions

    J. Int. Neuropsychol. Soc.

    (2002)
  • M.E. Ballard et al.

    Low dopamine D2/D3 receptor availability is associated with steep discounting of delayed rewards in methamphetamine dependence

    Int. J. Neuropsychopharmacol.

    (2015)
  • D.S. Bassett et al.

    Hierarchical organization of human cortical networks in health and schizophrenia

    J. Neurosci.

    (2008)
  • R.M. Bilder et al.

    Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

    Am. J. Psychiatry

    (2000)
  • R.M. Bilder et al.

    Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

    Am. J. Psychiatry

    (2002)
  • A. Borkowska et al.

    Risperidone treatment of schizophrenia: improvement in psychopathology and neuropsychological tests

    Neuropsychobiology

    (2002)
  • A.M. Brickman et al.

    Neuropsychological functioning in first-break, never-medicated adolescents with psychosis

    J. Nerv. Ment. Dis.

    (2004)
  • G. Brix et al.

    Performance evaluation of a whole-body PET scanner using the NEMA protocol. National electrical manufacturers association

    J. Nucl. Med.

    (1997)
  • M.S. Buchsbaum et al.

    Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia

    Acta Psychiatr. Scand. Suppl.

    (1999)
  • B.R. Buchsbaum et al.

    Meta-analysis of neuroimaging studies of the Wisconsin card-sorting task and component processes

    Hum. Brain Mapp.

    (2005)
  • M.S. Buchsbaum et al.

    Relative glucose metabolic rate higher in white matter in schizophrenia

    Am. J. Psychiatr.

    (2007)
  • J.W. Buckholtz et al.

    Dopaminergic network differences in human impulsivity

    Science

    (2010)
  • P.F. Buckley

    Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications

    Neuropsychiatr. Dis. Treat.

    (2005)
  • E. Bullmore et al.

    The economy of brain network organization. Nature reviews

    Neuroscience

    (2012)
  • J. Cohen

    Statistical Power Analysis for the Behavioral Sciences

    (1969)
  • A. Crider

    Perseveration in schizophrenia

    Schizophr. Bull.

    (1997)
  • V.J. Cunningham et al.

    Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro

    J. Cereb. Blood Flow Metab.

    (1991)
  • D. Delis et al.

    The California Verbal Learning Test

    (1987)
  • Cited by (13)

    • Reading abilities and dopamine D<inf>2</inf>/D<inf>3</inf> receptor availability: An inverted U-shaped association in subjects with schizophrenia

      2021, Brain and Language
      Citation Excerpt :

      Cluster correlations were significantly weaker in subjects with schizophrenia than in healthy subjects in the left superior parietal lobule, right angular gyrus and precuneus in the parietal lobe, as well as in the right orbitofrontal, left rectus and inferior frontal gyri in the frontal lobe. Overall, healthy subjects tended to show positive correlations between regional 18F-fallypride binding potential and WRAT4 reding scores while these correlations were nonsignificant or negative in antipsychotic-naïve subjects with schizophrenia, and this finding is similar to our earlier results for executive functions (Vyas et al., 2018). As a normally positive association between gray matter metabolism and dopamine D2/D3 receptor availability is also diminished in subjects with schizophrenia (Mitelman et al., 2020), the disrupted modulating role of dopamine in metabolic responses to cognitive tasks may prove a general phenomenon in schizophrenia, so that similar results could conceivably be expected for other cognitive skills implicated in its psychopathology.

    • Relationship between white matter glucose metabolism and fractional anisotropy in healthy and schizophrenia subjects

      2020, Psychiatry Research - Neuroimaging
      Citation Excerpt :

      The exclusion criteria for healthy subjects were: 1) a personal or family history of psychiatric illness, intellectual disabilities, hereditary neurological disorders, as well as a personal history of cerebral infections, Parkinson's disease, stroke, head trauma with loss of consciousness for more than an hour, and serious medical illnesses; 2) psychoactive substance abuse in the 6 months preceding the study evaluation. There were no significant differences between healthy and schizophrenia subjects in performance on Wisconsin Card Sorting Test whereas patients with schizophrenia showed worse performance on most of the subtests of the California Verbal Learning Test, including long and short-delay recall, semantic clustering, recognition hits, discrimination, and number of false positives (see Vyas et al., 2018 for further testing details). T1-weighted MRI images were acquired using the 1.5T GE Signa NVi scanner (General Electric, Milwaukee, WI) with TR=24 ms, TE=5 ms, flip angle=40°, slice thickness=1.2 mm, pixel matrix=256 × 256, field of view=23 cm, total slices=128.

    • Research Applications of Positron Emission Tomography/Magnetic Resonance (PET/MR) Imaging in Schizophrenia

      2023, PET/MR: Functional and Molecular Imaging of Neurological Diseases and Neurosciences
    View all citing articles on Scopus
    View full text